2018-16813. Opioid Use Disorder: Endpoints for Demonstrating Effectiveness of Drugs for Medication-Assisted Treatment; Draft Guidance for Industry; Availability  

Document Information

Published:
08/07/2018
Department:
Health and Human Services Department
Agency:
Food and Drug Administration
EntryType:
Notice
Action:
Notice of availability.
Document Number:
2018-16813
Dates:
Submit either electronic or written comments on the draft guidance by October 9, 2018 to ensure that the Agency considers your comment on this draft guidance before it begins work on the final version of the guidance.
Pages:
38699-38700 (2 pages)
Docket Numbers:
Docket No. FDA-2018-D-2382
SectionNoes:
PDF File:
2018-16813.pdf